Clinical Trials on Gram-negative Bacteria in Belgium

Total 293 results

Hellenic Institute for the Study of Sepsis
European Commission

Completed

Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System (INCLASS)

Pneumonia | Sepsis | Mortality | Biomarkers | Respiratory Distress Syndrome | Multiple Organ Failure | Gram-Negative Bacteria Infection

Greece, Belgium
GlaxoSmithKline

Completed

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

Infections, Meningococcal

Belgium
GlaxoSmithKline

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Infections, Meningococcal

Belgium
GlaxoSmithKline
Biological E. Limited

Recruiting

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Typhoid Fever

Belgium
Novartis

Completed

Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults

Typhoid Fever

Belgium
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)

Typhoid Fever

Belgium
Novartis

Completed

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Typhoid Fever

Belgium
Hospital Clinic of Barcelona

Recruiting

Arrangement of Collecting Venules for the Endoscopic Diagnosis of Helicobacter Pylori (MOTIVATION)

Helicobacter Pylori Infection

Spain, Belgium, Germany
GlaxoSmithKline
Bill and Melinda Gates Foundation; Wellcome Trust; Biomedical Advanced Research... and other collaborators

Recruiting

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever

Salmonella Infections

Belgium, Malawi
University Medical Centre Ljubljana

Withdrawn

The Effect of Probiotic Combination on Helicobacter Pylori Infection in Children (Gastrus)

Helicobacter Infections

Israel, Belgium, Croatia, Germany, Slovenia
Institute of Tropical Medicine, Belgium

Completed

Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea (ResistAZM)

Neisseria Gonorrhoeae

Belgium
GlaxoSmithKline

Completed

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Whooping Cough

Belgium
Bharat Biotech International Limited

Recruiting

To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131) (Hillchol131)

Cholera

India
Institute of Tropical Medicine, Belgium
University Hospital, Antwerp

Completed

Treponema Pallidum-specific Proteomic Changes in Patients With Incident Syphilis Infection (SeTPAT)

Syphilis

Belgium
Dr Philippe CLEVENBERGH

Completed

Nosocomial and Community Acquired Legionella Pneumophila Pneumonia.

Legionnaires' Disease

Belgium
Bharat Biotech International Limited

Active, not recruiting

A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131). (Hillchol)

Cholera

India
Universiteit Antwerpen
National Institute of Hygiene and Epidemiology, Vietnam

Completed

Pertussis (Tdap) Vaccination in Pregnancy

Pertussis | Pregnancy

Belgium, Vietnam
Centre Hospitalier Universitaire Saint Pierre
Université Libre de Bruxelles

Not yet recruiting

Maternal Determinants of Infant Immunity to Pertussis (MADI-02)

Pertussis | Maternal-Fetal Relations | Vaccination; Infection | Immunoglobulins

Belgium
Universiteit Antwerpen
University Hospital, Antwerp; Research Foundation Flanders; Université Libre...

Active, not recruiting

Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants (MAMA)

Pertussis

Belgium
Novartis

Completed

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Pertussis

Belgium
Valneva Austria GmbH

Completed

Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

Pseudomonas Aeruginosa Infection

Spain, Germany, Belgium, Austria, Czech Republic, Hungary
Universitaire Ziekenhuizen KU Leuven

Completed

Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia

Staphylococcus Aureus Bacteraemia

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa (MET55)

Healthy Volunteers (Meningococcal Infection)

India, South Africa
Pherecydes Pharma

Unknown

Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients (PHAGOBURN)

Wound Infection

Belgium, France, Switzerland
University Hospital, Ghent
GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company; Novartis Vaccines; University... and other collaborators

Completed

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

Prevention of Infections With Bordetella Pertussis

Belgium
AZ Sint-Jan AV
Paul Tulkens, Louvain drug research institute, belgium; Francoise Van Bambeke... and other collaborators

Completed

Temocillin Pharmacokinetic in Hemodialysis

Gram-Negative Bacterial Infections | Renal Failure Chronic Requiring Hemodialysis

Belgium
Pfizer

Completed

Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.

Lyme Borreliosis

United States, Germany, Belgium
Novartis Vaccines

Completed

Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

Pertussis | Whooping Cough | Tetanus | Diphtheria | Lockjaw

Belgium
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Meningococcal Infections

Belgium, Czech Republic, Germany, Italy, Spain, United Kingdom
Universitaire Ziekenhuizen KU Leuven

Completed

Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

Gram-Positive Bacterial Infections

Belgium
GlaxoSmithKline

Active, not recruiting

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

Infections, Meningococcal

United States, Australia, Finland, Poland, Belgium, Brazil, Sweden, Turkey
Institute of Tropical Medicine, Belgium

Completed

GonoScreen: Efficacy of Screening STIs in MSM (GonoScreen)

Chlamydia Trachomatis Infection | Neisseria Gonorrhoeae Infection

Belgium
Janssen Research & Development, LLC

Active, not recruiting

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

Extraintestinal Pathogenic Escherichia Coli Prevention

United States, France, Belgium, Spain, Netherlands
GlaxoSmithKline

Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age

Infections, Meningococcal

Germany, Canada, Australia, Belgium, Italy
Global Antibiotics Research and Development Partnership

Active, not recruiting

Zoliflodacin in Uncomplicated Gonorrhoea

Gonorrhea

United States, Belgium, South Africa, Netherlands, Thailand
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

Clostridium Infections

Belgium
Bert Vaes

Recruiting

The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage

Pneumococcal Infections

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Tuberculosis

Belgium
Pfizer
Valneva Austria GmbH

Completed

Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis

Lyme Borreliosis, Nervous System

Belgium, United States
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

Infections, Staphylococcal

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults

Pneumococcal Disease

Belgium
Minervax ApS
Iqvia Pty Ltd

Completed

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

Group B Streptococcal Infections

Belgium
Institute of Tropical Medicine, Belgium
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique... and other collaborators

Completed

IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres (IDIS)

Fever | Salmonella Infections | Blood Stream Infections | Salmonella Septicemia | Parasitic Infections

Belgium, Cambodia, Congo, The Democratic Republic of the
Queen Fabiola Children's University Hospital
Centre National de Référence S.aureus

Unknown

Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center. (PAPED)

Cross Infection | Cystic Fibrosis | Pseudomonas Aeruginosa

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Tuberculosis (TB)

Belgium
GlaxoSmithKline
Aeras

Completed

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Tuberculosis

Belgium
Centre Hospitalier Universitaire Saint Pierre

Suspended

Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes

Tuberculosis

Belgium
GlaxoSmithKline

Completed

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Prophylactic Pneumococcal Diseases

Belgium
GlaxoSmithKline

Completed

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
GlaxoSmithKline

Completed

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium

3

Subscribe